129 related articles for article (PubMed ID: 25572685)
1. Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases.
Knox RD; Luey N; Sioson L; Kedziora A; Clarkson A; Watson N; Toon CW; Cussigh C; Pincott S; Pillinger S; Salama Y; Evans J; Percy J; Schnitzler M; Engel A; Gill AJ
Ann Surg Oncol; 2015 Sep; 22(9):2988-96. PubMed ID: 25572685
[TBL] [Abstract][Full Text] [Related]
2. Flat and polypoid adenocarcinomas of the colorectum: A comparative histomorphologic analysis of 47 cases.
Nasir A; Boulware D; Kaiser HE; Bodey B; Siegel S; Crawley S; Yeatman T; Marcet JE; Coppola D
Hum Pathol; 2004 May; 35(5):604-11. PubMed ID: 15138936
[TBL] [Abstract][Full Text] [Related]
3. Medullary carcinoma in the colorectum: a systematic review and meta-analysis.
Pyo JS; Sohn JH; Kang G
Hum Pathol; 2016 Jul; 53():91-6. PubMed ID: 27001432
[TBL] [Abstract][Full Text] [Related]
4. Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma.
Wick MR; Vitsky JL; Ritter JH; Swanson PE; Mills SE
Am J Clin Pathol; 2005 Jan; 123(1):56-65. PubMed ID: 15762280
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implications.
Lee LH; Yantiss RK; Sadot E; Ren B; Calvacanti MS; Hechtman JF; Ivelja S; Huynh B; Xue Y; Shitilbans T; Guend H; Stadler ZK; Weiser MR; Vakiani E; Gönen M; Klimstra DS; Shia J
Hum Pathol; 2017 Apr; 62():74-82. PubMed ID: 28034727
[TBL] [Abstract][Full Text] [Related]
7. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival.
Lanza G; Gafà R; Matteuzzi M; Santini A
J Clin Oncol; 1999 Aug; 17(8):2429-38. PubMed ID: 10561306
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
[TBL] [Abstract][Full Text] [Related]
9. Is medullary carcinoma of the colon underdiagnosed? An audit of poorly differentiated colorectal carcinomas in a large national health service teaching hospital.
Scott N; West NP; Cairns A; Rotimi O
Histopathology; 2021 Jun; 78(7):963-969. PubMed ID: 33247957
[TBL] [Abstract][Full Text] [Related]
10. Medullary colorectal carcinoma. Do we really know it?
Puerta Vicente A; Vilar Tabanera A; García Pérez JC
Rev Esp Enferm Dig; 2020 Jul; 112(7):579-580. PubMed ID: 32579007
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological features of colorectal cancer in patients at a community hospital in Puerto Rico.
Cotto M; Rosado-Orozco KE; Rizek R; Fraguada LA; Brunet V; Cerra JJ; Sánchez A; Cabanillas F; Muñoz-Masso C; Tirado-Gómez M; Maldonado N
P R Health Sci J; 2014 Jun; 33(2):65-70. PubMed ID: 24964640
[TBL] [Abstract][Full Text] [Related]
12. [Development of molecular-pathologic entities of colorectal cancer].
Kirchner T; Reu S
Pathologe; 2008 Nov; 29 Suppl 2():264-9. PubMed ID: 18841367
[TBL] [Abstract][Full Text] [Related]
13. Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma.
Zannier F; Angerilli V; Spolverato G; Brignola S; Sandonà D; Balistreri M; Sabbadin M; Lonardi S; Bergamo F; Mescoli C; Scarpa M; Bao QR; Dei Tos AP; Pucciarelli S; Urso ELD; Fassan M
Pathol Res Pract; 2023 Mar; 243():154366. PubMed ID: 36774759
[TBL] [Abstract][Full Text] [Related]
14. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
15. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
17. Medullary carcinoma of the large intestine: a population based analysis.
Thirunavukarasu P; Sathaiah M; Singla S; Sukumar S; Karunamurthy A; Pragatheeshwar KD; Lee KK; Zeh H; Kane KM; Bartlett DL
Int J Oncol; 2010 Oct; 37(4):901-7. PubMed ID: 20811712
[TBL] [Abstract][Full Text] [Related]
18. Improved survival in young women with colorectal cancer.
Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 Patients.
Fuchs TL; Sioson L; Sheen A; Jafari-Nejad K; Renaud CJ; Andrici J; Ahadi M; Chou A; Gill AJ
Am J Surg Pathol; 2020 Apr; 44(4):536-544. PubMed ID: 31743129
[TBL] [Abstract][Full Text] [Related]
20. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]